Global Oncology Drugs Market - Competitive
Analysis And Revenue Growth
Oncology drugs and medications have become a blooming business for players in the
pharmaceutical industry. Major pharmaceutical companies are focused on manufacturing and
development of oncology drug. Market players have oncology drugs in pipeline, which are
expected to be in the market as potential medications in near future. Also, the global oncology
market is expected to gain a significant traction with the increasing prevalence of cancer.
According to the National Cancer Institute, cancer is among the leading causes of death
worldwide, which accounted for around 14 million new cases and 8.2 million cancer-related
deaths in 2012. The number of new cancer cases is projected to rise to 22 million in near
future. The major competitors are focused on developing efficient treatment for specific type of
cancer which is expected to be a prominent factor to augment the global oncology drugs
market.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1437
Major manufacturers in the oncology drugs market include:
• Roche
• Celgene
• Johnson & Johnson
• Pfizer
• Sanofi
• Bristol-Meyers Squibb
• Novartis
• GlaxoSmithKline
• Eli Lily
• Merck & Co.
Top 5 company described for competitive analysis in detail: